IHS Chemical Week

Regions :: India/Pakistan

Hospira to Acquire API Facility in India for $200 Million

7:36 AM MDT | August 29, 2012 | Deepti Ramesh

Hospira (Lake Forest, IL), the world's leading provider of injectable drugs and infusion technologies, says it has signed an agreement to acquire an active pharmaceutical ingredient (API) manufacturing facility, together with an associated research and development (R&D) facility from Orchid Chemicals & Pharmaceuticals (Chennai, India), a leading Indian pharmaceutical company, for about $200 million. The API manufacturing facility is located at Aurangabad, India and it employs about 640 people, and the associated R&D facility is located at Chennai...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa